Vistin Pharma ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vistin Pharma ASA with three other
companies in this sector in Norway:
sales of 150.91 million Norwegian Kroner [US$17.74 million]
of which 57%
was Hexvix/Cysview Own Sales),
Biotec Pharmacon ASA
(66.69 million Norwegian Kroner [US$7.84 million]
(66.42 million Norwegian Kroner [US$7.81 million]
of which 100%
was Vitamin K2/MenaQ7).